Matched Signals
No stored keyword or signal matches were recorded for this activity window.
Correspondence Activity Detail
Aspire Biopharma Holdings, Inc. (ASBP)
Activity window: Sep. 25, 2025 to Sep. 24, 2026
Filings In This Window
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Apr. 13, 2026 | CORRESP | Neutral/Informational | Moderate | Aspire Biopharma Holdings, Inc. has submitted a request to the SEC to accelerate the effective date of their Registration Statement on Form S-1. They are seeking for it to be decl… | Read Filing EDGAR |
| Feb. 24, 2026 | UPLOAD | Neutral/Informational | Low | The SEC correspondence dated February 24, 2026, informs Aspire Biopharma Holdings, Inc. that their registration statement on Form S-1, filed on February 17, 2026, will not be revi… | Read Filing EDGAR |
| Dec. 11, 2025 | CORRESP | Neutral/Informational | Moderate | Aspire Biopharma Holdings, Inc. has submitted a request to the SEC to accelerate the effective date of their registration statement on Form S-1. They are seeking for it to become … | Read Filing EDGAR |
| Sep. 26, 2025 | CORRESP | Neutral/Informational | Moderate | Aspire Biopharma Holdings, Inc. has submitted a request to the SEC to accelerate the effective date of their Registration Statement on Form S-1. They are seeking for it to be decl… | Read Filing EDGAR |
Notable 8-Ks In This Window
No notable 8-Ks were stored for this company in this activity window.